<DOC>
	<DOCNO>NCT00002169</DOCNO>
	<brief_summary>The purpose study see safe effective give Viracept AIDS patient already treat cytomegalovirus ( CMV ) retinitis .</brief_summary>
	<brief_title>A Study Viracept AIDS Patients With Cytomegalovirus Retinitis</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Cytomegalovirus Retinitis</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . Newly diagnose first progression CMV retinitis . Exclusion Criteria Prior Medication : Excluded : Prior therapy ( le 2 week ) protease inhibitor saquinavir .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1999</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Placebos</keyword>
	<keyword>Antiviral Agents</keyword>
	<keyword>Cytomegalovirus Retinitis</keyword>
	<keyword>Treatment Outcome</keyword>
	<keyword>Nelfinavir</keyword>
</DOC>